stivarga
Generic: regorafenib
Labeler: bayer healthcare pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
stivarga
Generic Name
regorafenib
Labeler
bayer healthcare pharmaceuticals inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
regorafenib 40 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50419-171
Product ID
50419-171_8f47fb28-9855-4482-b807-e98c425c2a4e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA203085
Listing Expiration
2027-12-31
Marketing Start
2012-09-27
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50419171
Hyphenated Format
50419-171
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
stivarga (source: ndc)
Generic Name
regorafenib (source: ndc)
Application Number
NDA203085 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 40 mg/1
Packaging
- 210 BOTTLE in 1 BOX (50419-171-00) / 28 TABLET, FILM COATED in 1 BOTTLE
- 3 BOTTLE, PLASTIC in 1 BOX (50419-171-03) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-01)
- 1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06) / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-05)
Packages (4)
50419-171-00
210 BOTTLE in 1 BOX (50419-171-00) / 28 TABLET, FILM COATED in 1 BOTTLE
50419-171-03
3 BOTTLE, PLASTIC in 1 BOX (50419-171-03) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-01)
50419-171-04
1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
50419-171-06
4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06) / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-05)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8f47fb28-9855-4482-b807-e98c425c2a4e", "openfda": {"unii": ["MGN125FS9D"], "rxcui": ["1312402", "1312408"], "spl_set_id": ["824f19c9-0546-4a8a-8d8f-c4055c04f7c7"], "manufacturer_name": ["Bayer HealthCare Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "210 BOTTLE in 1 BOX (50419-171-00) / 28 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "50419-171-00", "marketing_start_date": "20120927"}, {"sample": false, "description": "3 BOTTLE, PLASTIC in 1 BOX (50419-171-03) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-01)", "package_ndc": "50419-171-03", "marketing_start_date": "20120927"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "50419-171-04", "marketing_start_date": "20120927"}, {"sample": false, "description": "4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06) / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-05)", "package_ndc": "50419-171-06", "marketing_start_date": "20210501"}], "brand_name": "Stivarga", "product_id": "50419-171_8f47fb28-9855-4482-b807-e98c425c2a4e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Kinase Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]"], "product_ndc": "50419-171", "generic_name": "regorafenib", "labeler_name": "Bayer HealthCare Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Stivarga", "active_ingredients": [{"name": "REGORAFENIB", "strength": "40 mg/1"}], "application_number": "NDA203085", "marketing_category": "NDA", "marketing_start_date": "20120927", "listing_expiration_date": "20271231"}